Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedieraROCO:5398 -1.05%59 FCF Margin % is 15.52% as of Jun. 2026, which is 2943% above its 10-year median of 0.51. GuruFocus rates ROCO:5398 with a GF Score™ of 59/100 and a GF Value™ of NT$17.49 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 961 Drug Manufacturers companies, Mediera ranks better than 89.39% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Mediera's Free Cash Flow for the
three
months ended in Jun. 2026 was NT$6.1 Mil. Mediera's Revenue for the
three
months ended in Jun. 2026 was NT$39.2 Mil. Therefore, Mediera's FCF Margin % for the quarter that ended in Jun. 2026 was 15.52%.
The historical data trend for Mediera's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mediera's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mediera FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mediera's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Mediera's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediera (ROCO:5398) has a FCF Margin % of 15.52% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Mediera and its competitors. This is 2943% above median its historical median of 0.51. According to the industry distribution chart, Mediera ranks #102 out of 961 companies in the Drug Manufacturers industry, placing it in the top 10.6%.
Is Mediera's FCF Margin % too high?
Mediera's current FCF Margin % of 15.52% is 2943% above median its 10-year median of 0.51. The Drug Manufacturers industry median FCF Margin % is 2.67. Mediera's value of 15.52% is 481.3% above this industry median. Based on the distribution chart, Mediera ranks #102 out of 961 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Mediera has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mediera's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mediera ranks #102 out of 961 companies for FCF Margin %. This places Mediera in the top 11% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.67. Mediera's value of 15.52% is 481.3% above this benchmark. While the company's 10-year median is 0.51 vs. the industry median of 2.67, Mediera has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.67, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mediera's current FCF Margin % of 15.52% is 481.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Mediera and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mediera's current FCF Margin % is 15.52%, which is 2943% above median its own 10-year median of 0.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediera stock overvalued right now?
Based on GuruFocus' analysis, Mediera (ROCO:5398) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$17.49, compared to a current price of NT$14.20 — trading 18.8% below its estimated fair value. The current FCF Margin % is 15.52%, which is 2943% above median its 10-year median of 0.51 and 481.3% above the Drug Manufacturers industry median of 2.67. Mediera's overall GF Score™ is 59/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Mediera (ROCO:5398), the current FCF Margin % is 15.52% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mediera (ROCO:5398) Overvalued in 2026?
Based on GuruFocus' analysis, Mediera stock appears to be undervalued.
The current stock price of NT$14.20 is trading 18.8% below its estimated GF Value™ of NT$17.49.
GuruFocus considers Mediera to be Modestly Undervalued.
Key valuation signals for ROCO:5398:
FCF Margin %: 15.52% (2943% above median its 10-year median of 0.51)
GF Value™: NT$17.49 vs. price of NT$14.20 (18.8% below fair value)
Industry Position: 481.3% above the Drug Manufacturers median (#102 of 961)
No single metric tells the full story. See the ROCO:5398 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:5398 has been successfully added to your 
